Q1 2014 13F Holders as of 31 Mar 2014
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
4,586,742
-
Share change
-
+4,586,742
-
Total reported value
-
$45,781,000
-
Price per share
-
$10.00
-
Number of holders
-
32
-
Value change
-
+$45,781,000
-
Number of buys
-
32
Institutional Holders of ARGOS THERAPEUTICS INC - COM (ARGS) as of Q1 2014
As of 31 Mar 2014,
ARGOS THERAPEUTICS INC - COM (ARGS) was held by
32 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
4,586,742 shares.
The largest 10 holders included
WASATCH ADVISORS INC, MARXE AUSTIN W & GREENHOUSE DAVID M, CAISSE DE DEPOT ET PLACEMENT DU QUEBEC, WALL STREET ASSOCIATES, Pine River Capital Management L.P., ALTRINSIC GLOBAL ADVISORS LLC, Alyeska Investment Group, L.P., VANGUARD GROUP INC, BlackRock Fund Advisors, and EDELMAN FINANCIAL GROUP INC..
This page lists
32
institutional shareholders reporting positions in this security
for the Q1 2014 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.